This inventor holds 1 USPTO granted patent. Top assignee: Morphochem Gmbh. Active years: 2007.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2007
Title: Katrin Illgen: Innovator in Factor Xa Inhibition
Introduction
Katrin Illgen is a prominent inventor based in Munich, Germany. She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that inhibit Factor Xa activity. Her work is crucial for advancing treatments for diseases mediated by this enzyme.
Latest Patents
Katrin holds a patent for "Compounds that inhibit factor Xa activity." This invention relates to specific compounds or their pharmaceutically acceptable salts, solvates, hydrates, or formulations. These compounds are designed to inhibit Factor Xa and can be utilized in the treatment and prevention of various diseases associated with Factor Xa activity. She has 1 patent to her name.
Career Highlights
Katrin Illgen is associated with Morphochem GmbH, a company focused on innovative pharmaceutical solutions. Her role at Morphochem has allowed her to explore and develop groundbreaking therapeutic compounds.
Collaborations
Katrin has collaborated with notable colleagues, including Sven Nerdinger and Thilo Fuchs. Their combined expertise contributes to the advancement of research and development in their field.
Conclusion
Katrin Illgen's work in the inhibition of Factor Xa activity represents a significant advancement in pharmaceutical innovation. Her contributions are vital for the development of new treatments, showcasing her dedication to improving healthcare outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile